NYSE:CGC - Canopy Growth Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $44.38 -1.66 (-3.61 %) (As of 03/22/2019 04:00 PM ET)Previous Close$46.04Today's Range$44.3030 - $46.1452-Week Range$18.93 - $59.25Volume6.61 million shsAverage Volume9.94 million shsMarket Capitalization$14.85 billionP/E Ratio-138.69Dividend YieldN/ABeta4.29 ProfileDiscussionAnalyst RatingsChartEarningsInstitutional OwnershipHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Canopy Growth Corp. engages in the production and sale of medical cannabis. The company offers products including oils and concentrates, soft gel capsules, and hemp. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada. Receive CGC News and Ratings via Email Sign-up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Medicinals & botanicals Sub-IndustryCannabis SectorMedical Current SymbolNYSE:CGC Previous Symbol CUSIPN/A CIKN/A Webwww.canopygrowth.com Phone855-558-9333Debt Debt-to-Equity Ratio0.10 Current Ratio17.85 Quick Ratio17.12Price-To-Earnings Trailing P/E Ratio-138.69 Forward P/E Ratio-37.29 P/E GrowthN/A Sales & Book Value Annual Sales$60.79 million Price / Sales244.31 Cash FlowN/A Price / Cash FlowN/A Book Value$4.87 per share Price / Book9.11Profitability EPS (Most Recent Fiscal Year)($0.32) Net Income$-54,880,000.00 Net Margins-267.40% Return on Equity-14.39% Return on Assets-11.12%Miscellaneous Employees1,033 Outstanding Shares334,652,000Market Cap$14.85 billion Next Earnings Date6/26/2019 (Estimated) OptionableOptionable Canopy Growth (NYSE:CGC) Frequently Asked Questions What is Canopy Growth's stock symbol? Canopy Growth trades on the New York Stock Exchange (NYSE) under the ticker symbol "CGC." When is Canopy Growth's next earnings date? Canopy Growth is scheduled to release their next quarterly earnings announcement on Wednesday, June 26th 2019. View Earnings Estimates for Canopy Growth. What price target have analysts set for CGC? 8 brokerages have issued 12-month price targets for Canopy Growth's stock. Their predictions range from $46.27 to $61.00. On average, they anticipate Canopy Growth's share price to reach $55.7567 in the next year. This suggests a possible upside of 25.6% from the stock's current price. View Analyst Price Targets for Canopy Growth. What is the consensus analysts' recommendation for Canopy Growth? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Canopy Growth. Has Canopy Growth been receiving favorable news coverage? News coverage about CGC stock has been trending positive recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Canopy Growth earned a media sentiment score of 2.2 on InfoTrie's scale. They also assigned press coverage about the marijuana producer a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. Who are some of Canopy Growth's key competitors? Some companies that are related to Canopy Growth include Actelion (ALIOF), Aurora Cannabis (ACB), Tilray (TLRY), STADA Arzneimittel (STDAF), Cronos Group (CRON), USANA Health Sciences (USNA), CV Sciences (CVSI), Canopy Rivers (RIV), Chromadex (CDXC), Foamix Pharmaceuticals (FOMX), Mediwound (MDWD), Natural Alternatives International (NAII), China Jo-Jo Drugstores (CJJD), Mannatech (MTEX) and Cyanotech (CYAN). What other stocks do shareholders of Canopy Growth own? Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Growth investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), General Electric (GE), Cronos Group (CRON), Aurora Cannabis (ACB), Tilray (TLRY), Aurora Cannabis (ACBFF), Aurora Cannabis (ACB) and GW Pharmaceuticals PLC- (GWPH). Who are Canopy Growth's key executives? Canopy Growth's management team includes the folowing people: Bruce Linton, Chairman & Co-Chief Executive OfficerMark Zekulin, President & Co-Chief Executive OfficerTimothy R. Saunders, Chief Financial Officer & Executive Vice PresidentAmanda Daley, Vice President-MedicalRu Wadasinghe, Chief Information Officer Who are Canopy Growth's major shareholders? Canopy Growth's stock is owned by a variety of of retail and institutional investors. Top institutional investors include ETF Managers Group LLC (0.64%), Connor Clark & Lunn Investment Management Ltd. (0.63%), Macquarie Group Ltd. (0.57%), Norges Bank (0.49%), TD Asset Management Inc. (0.34%) and Bank of Nova Scotia (0.17%). Which major investors are selling Canopy Growth stock? CGC stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Investments LP, D. E. Shaw & Co. Inc., Connor Clark & Lunn Investment Management Ltd., Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Bank of America Corp DE, Essex Investment Management Co. LLC, Two Sigma Advisers LP and Macquarie Group Ltd.. Which major investors are buying Canopy Growth stock? CGC stock was acquired by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, Norges Bank, Bank of New York Mellon Corp, Bank of Nova Scotia, Legal & General Group Plc, Intact Investment Management Inc., Mackenzie Financial Corp and Aviva PLC. How do I buy shares of Canopy Growth? Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Canopy Growth's stock price today? One share of CGC stock can currently be purchased for approximately $44.38. How big of a company is Canopy Growth? Canopy Growth has a market capitalization of $14.85 billion and generates $60.79 million in revenue each year. The marijuana producer earns $-54,880,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. Canopy Growth employs 1,033 workers across the globe. What is Canopy Growth's official website? The official website for Canopy Growth is http://www.canopygrowth.com. How can I contact Canopy Growth? Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The marijuana producer can be reached via phone at 855-558-9333 or via email at [email protected] MarketBeat Community Rating for Canopy Growth (NYSE CGC)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 297 (Vote Outperform)Underperform Votes: 279 (Vote Underperform)Total Votes: 576MarketBeat's community ratings are surveys of what our community members think about Canopy Growth and other stocks. Vote "Outperform" if you believe CGC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: Why do companies engage in swaps?